Basic Salofalk Information

• INN (International Nonproprietary Name): Mesalazine (mesalamine; 5‑aminosalicylic acid, 5‑ASA).
• Brand Names Available In United Kingdom: Asacol, Pentasa, Mezavant (Lialda in some markets), Salofalk; formulations include delayed‑release tablets and rectal forms.
• ATC Code: A07EC02 (A07: Drugs For Treatment Of Inflammatory Bowel Disease; E: Intestinal Anti‑Inflammatory Agents; C: Aminosalicylic Acid And Similar Agents).
• Forms & Dosages: Delayed‑release tablets 400 mg and 800 mg (Asacol examples) in blister packs or bottles (30/60/90), plus rectal enemas and suppositories depending on brand and local supply.
• Manufacturers In United Kingdom: Marketed brands and generics are supplied by manufacturers and distributors such as Tillotts Pharma, Meda Pharma and other licensed suppliers; local wholesalers supply branded and generic mesalazine.
• Registration Status In United Kingdom: Prescription‑only medicine licensed for induction and maintenance of remission in ulcerative colitis; product information and pack leaflets state UK/EEA regulatory acceptance.
• OTC / Rx Classification: Prescription (Rx) only in the UK; medical supervision and monitoring are required.

Essential Practical Advice For UK Patients

Keep all prescriptions and repeat prescriptions through the NHS system or a registered UK online pharmacy such as Boots, LloydsPharmacy, Superdrug or an NHS‑approved online service.

Salofalk is part of the mesalazine family; related brands include Asacol, Pentasa and Mezavant/Lialda.

Do not buy mesalazine from unregulated sites because these products are prescription‑only.

Store tablets in the original packaging at 15–30°C and away from moisture and children.

Carry a steroid/IBD card if you have one and tell emergency staff you take mesalazine.

Avoid mesalazine if you have a known allergy to mesalazine or salicylates, or in severe renal impairment; discuss pregnancy and breastfeeding with your clinician.

Report acute worsening of bloody diarrhoea or new chest pain immediately to your GP or A&E.

Set pill alarms, keep a spare pack in your work bag and take a dose with a small snack if you feel nauseous.

Expect baseline and periodic blood tests for renal function and liver enzymes via your NHS GP or specialist while taking mesalazine.

Morning Vs Evening Dosing

Many patients worry about when to take mesalazine and whether timing matters.

Aim for consistent timing each day to help adherence and steady exposure.

Typical induction dosing for mild–moderate ulcerative colitis is 2.4–4.8 g/day given orally in divided doses, for example 800 mg three times daily to reach 2.4 g/day and higher as prescribed.

Splitting doses helps smooth plasma levels and reduces stomach upset for some patients.

Common UK routines are a dose with breakfast, another at lunchtime and an evening dose with dinner which works well for shift workers and parents.

If your clinician prescribes a twice‑daily extended‑release product take doses roughly 12 hours apart to maintain even delivery.

Use phone alarms, pill boxes or repeat dispensing reminders set up at Boots or LloydsPharmacy to improve adherence.

If you miss a dose, take it as soon as you remember unless it is almost time for the next dose; do not double up.

Taking With Or Without Meals (UK Diet Habits)

Patients often ask whether to take mesalazine with food on a busy British morning.

Mesalazine can be taken with or without food, but taking it with a light UK‑style breakfast such as toast or porridge can reduce nausea for sensitive patients.

Avoid heavy alcohol intake around dosing because alcohol may irritate the gut even though it does not stop the drug’s action.

Practical tips:

• Use a pill box divided by day and time to organise 400 mg or 800 mg tablets.
• Set recurring phone alarms for each scheduled dose to support patient adherence.
• Keep a workplace spare pack and carry a copy of your NHS prescription when travelling.
• For nausea, take the tablet with a small snack rather than on an empty stomach.

Who Should Avoid It (MHRA Warnings)

Patients want to know whether mesalazine is safe for them given other conditions.

Absolute contraindications include allergy to mesalazine/mesalamine or salicylate‑containing agents such as aspirin or sulfasalazine.

Severe renal impairment is a contraindication; mesalazine is renally excreted and can cause rare nephrotoxicity.

People with prior mesalazine‑induced nephritis or serious hypersensitivity should not restart without specialist review.

If you have a history of kidney stones, chronic kidney disease or significant liver impairment discuss this with your GP because monitoring or alternative therapy may be needed.

MHRA and BNF guidance require baseline renal function and periodic monitoring during treatment.

Inform your GP or specialist immediately about new rash, fever, chest pain or breathing difficulties as these may be signs of serious reactions.

Activities To Limit (Driving, Work Safety)

Many patients ask if mesalazine affects driving or work.

Mesalazine rarely causes dizziness or fatigue but if you experience these effects avoid driving or operating heavy machinery until you feel safe.

During acute flares request workplace adjustments such as extra rest breaks and working close to facilities; your GP can provide a fit note if needed.

Red‑flag checklist — contact GP or A&E urgently for:

• Severe abdominal pain or marked worsening of diarrhoea with bleeding.
• Chest pain, shortness of breath or sudden unexplained fever.
• Rapidly spreading rash or signs of allergic reaction.

General Regimen (NHS Guidance)

Patients commonly ask what dose to expect from their NHS prescription.

For mild–moderate active ulcerative colitis typical adult induction doses are 2.4–4.8 g/day orally in divided doses, with examples such as 800 mg three times daily noted in British practice.

Maintenance regimens commonly use 1.6–2.4 g/day in divided doses to reduce relapse risk.

Brand and formulation matter: delayed‑release tablets such as Asacol (400 mg or 800 mg) are used for colonic disease while rectal suppositories or enemas are chosen for proctitis or distal disease.

Standard NHS practice is to start on an induction dose and step down to maintenance once remission is achieved under specialist guidance.

Follow local formulary recommendations and keep scheduled follow‑up appointments with your gastroenterology team or GP for monitoring.

Special Cases (Elderly, Comorbidities)

Older patients and those with other health problems need tailored dosing and monitoring.

Elderly patients should start at the lowest effective dose with closer renal monitoring because mesalazine is renally cleared and accumulation is a concern with reduced kidney function.

In renal impairment, mesalazine should be used with caution and is contraindicated in severe dysfunction; baseline creatinine and periodic checks are recommended.

For pregnancy and breastfeeding decisions clinicians balance benefit and risk; mesalazine may be continued if the gastroenterologist deems it appropriate.

Table: Typical Doses And Suggested Monitoring

Positive Reports From UK Patients

What do other patients say about mesalazine and Salofalk?

Many UK patients on forums and Patient.info report that mesalazine reduces bleeding and frequency when used for maintenance and allows return to normal routines and work.

Consistent dosing and regular GP or specialist follow‑up are commonly credited with improved quality of life.

Community pharmacists at Boots and LloydsPharmacy are often cited for help with repeat prescriptions and practical advice on storage and missed doses.

Some patients highlight benefit from combining oral and rectal formulations for distal disease to speed symptom control.

Common Challenges (Patient.info, NHS Forums)

People frequently ask what problems they might face on mesalazine.

Typical early issues include nausea, headaches or mild diarrhoea which often settle after a few weeks.

Some patients change brands or formulations (delayed‑release versus extended‑release) to improve tolerability.

Adherence can lapse during long maintenance phases; pill boxes, alarms and NHS repeat dispensing help keep treatment on track.

Checklist — talk to your clinician if you experience:

• Persistent nausea or worsening abdominal pain.
• New rash, fever or unexplained breathlessness.
• Ongoing blood loss despite treatment.

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Where should UK patients obtain Salofalk or other mesalazine products?

Salofalk and other mesalazine brands are prescription‑only and must be collected from a registered pharmacy such as Boots, LloydsPharmacy or Superdrug, or an NHS‑approved online pharmacy.

Registered pharmacists can advise on storage, missed doses and organise repeat dispensing to simplify monthly collections.

Stock of specific branded formulations may vary regionally, so follow the prescription to obtain the exact tablet strength or rectal form prescribed.

Price Comparison (NHS Prescription Charge Vs Private)

Cost is often a concern and depends on whether you are covered by NHS exemptions.

In England an NHS prescription charge applies unless you are exempt; in Scotland, Wales and Northern Ireland prescriptions are free for residents.

Private prescriptions vary in price and branded mesalazine tends to be more expensive than generics.

Ingredients Overview

Patients often want to know what is actually in their tablets.

The active ingredient in Salofalk and related products is mesalazine (mesalamine, 5‑ASA).

Tablets include excipients specific to each product; exact lists are printed in the pack leaflet.

Rectal enemas and suppositories contain mesalazine formulated for local delivery to the rectum and sigmoid colon.

Packages are commonly supplied as blister packs or bottles of 30, 60 or 90 tablets depending on the product.

Mechanism Basics Explained Simply

How does mesalazine work to calm gut inflammation?

Mesalazine acts topically on the intestinal mucosa as an anti‑inflammatory agent, helping to reduce mucosal inflammation in ulcerative colitis.

Delayed‑release tablets are formulated to release drug in the terminal ileum and colon to concentrate action locally and reduce systemic exposure.

Rectal delivery targets the distal colon directly, which is why enemas or suppositories are effective for proctitis and left‑sided disease.

• Oral Delayed‑Release → Releases mesalazine in terminal ileum/colon to treat colonic inflammation.
• Rectal Formulation → Direct topical effect in rectum and sigmoid for distal disease.

Approved Uses (MHRA Listing)

Patients ask what conditions mesalazine is licensed for in the UK.

Mesalazine is indicated for induction and maintenance of remission in ulcerative colitis, including preparations for proctitis and left‑sided disease.

Products such as Asacol have regulatory approval for these indications and are prescription‑only.

Mesalazine is not routinely recommended for Crohn’s disease where evidence is weaker.

Off‑Label Uses In UK Clinics

Clinicians sometimes use mesalazine off‑label in specific situations under specialist supervision.

Examples include treatment of pouchitis or adjunctive use in selected patients when guided by a gastroenterologist and local trust guidelines.

Rectal formulations are chosen when disease is limited to the rectum or sigmoid because local delivery is more effective for distal disease.

Food Interactions (Alcohol, Tea/Coffee)

Many patients worry about what to eat or drink while taking mesalazine.

There are no major food interactions recorded with mesalazine, but alcohol may aggravate gut symptoms and caffeine can increase bowel frequency in some people.

Taking doses with food can lessen transient nausea.

Avoid unregulated supplements and always show your medication list to the pharmacist before starting new over‑the‑counter remedies.

Drug Conflicts (MHRA Yellow Card Reports)

Patients should know which medicines can affect renal risk when taken with mesalazine.

Mesalazine may increase renal risk when used with other nephrotoxic drugs such as some NSAIDs and certain ACE inhibitors; concurrent use requires monitoring.

Concomitant azathioprine or 6‑mercaptopurine requires regular blood tests to check for additive effects and toxicity.

Report suspected adverse reactions via the MHRA Yellow Card scheme and inform your GP or pharmacist of all current medicines.

• Common interacting classes: NSAIDs, certain ACE inhibitors, immunosuppressants like azathioprine.
• Advise: Always show your full medicines list to the pharmacist.

Key UK & EU Studies 2022–2025

Patients often ask whether recent research supports continued use of mesalazine.

Recent UK and EU analyses continue to support 5‑ASA for induction and maintenance in ulcerative colitis, with higher induction doses (2.4–4.8 g/day) favoured for moderate flares.

Comparative work examines formulation bioavailability and practical differences between delayed‑release and extended‑release products with modest differences in remission rates.

Rectal 5‑ASA remains effective for distal disease.

Post‑marketing surveillance continues to flag rare renal adverse events and reinforces routine creatinine monitoring during therapy.

NHS Prescribing Alternatives With Pros/Cons Checklist

What are the other options on an NHS prescription?

NHS alternatives include Pentasa (sustained‑release), Mezavant (extended‑release) and generics, with choice guided by disease distribution, tolerance and local formulary.

Rectal Salofalk enemas or suppositories are used for distal disease because they deliver drug locally.

Suitability checklist when comparing products:

• Effectiveness at the intended site of inflammation (oral vs rectal).
• Gastrointestinal tolerance and side‑effect profile.
• Dosing frequency that fits your lifestyle.
• Cost and NHS formulary availability.

When To Ask For A Switch

Patients want to know when to ask their GP or specialist about trying another mesalazine formulation.

Request a trial of another product if you have intolerable side effects, adherence problems due to frequent dosing, or inadequate symptom control.

Pharmacists can advise on bioequivalence and practical substitution under NHS prescribing rules, but changes should be coordinated with the gastroenterology team.

Checklist — contact your clinician if you experience:

• Persistent side effects affecting daily life.
• Difficulty keeping to a three‑times‑daily schedule.
• Ongoing active symptoms despite treatment for 6–8 weeks.

MHRA Approval & NHS Prescribing Framework

Patients often ask how mesalazine is regulated in the UK.

Mesalazine products are prescription‑only under MHRA regulation and licensed for ulcerative colitis indications with product information on the pack.

NHS prescribing follows local trust formularies and BNF guidance; repeat prescribing is usually managed through the GP or pharmacist repeat dispensing services.

Check the pack leaflet for product‑specific contraindications and manufacturers listed on the carton.

Reporting & Safety Frameworks

How can adverse events be reported and tracked?

Report suspected adverse reactions through the MHRA Yellow Card scheme and keep your medication ID and leaflet to hand when reporting.

Routine renal and liver monitoring schedules are standard; contact your GP if tests are overdue or if you develop new systemic symptoms.

• Where to check product licence details: pack leaflet and MHRA or BNF online pages.
• How to report: MHRA Yellow Card online or via the app.

Will Mesalazine Make Me Infertile Or Affect Pregnancy?

Many patients planning pregnancy ask about fertility and safety.

Evidence suggests mesalazine is generally considered for use in pregnancy if benefits outweigh risks and should be discussed with your specialist.

Decisions are individualised and specialist guidance will consider disease control versus potential risks.

Monitor neonates for rare diarrhoea if mesalazine was used in pregnancy and discuss breastfeeding with your clinician.

How Long Before I Notice Benefit?

Patients want a realistic timeline for symptom improvement.

Some people see symptom improvement within 2–6 weeks of induction dosing, although full mucosal healing can take longer and is assessed by the specialist.

Common FAQ answers:

• “Can I stop once well?” — Maintenance therapy is usually advised to reduce relapse risk; speak with your specialist before stopping.
• “Can I take with other meds?” — Always check with the pharmacist for interactions.
• Contact points: GP, gastroenterology clinic, community pharmacist or NHS 111 for urgent concerns.

UK Pharmacist Counselling Style

What should you expect from a pharmacist when collecting mesalazine?

Pharmacists should confirm the exact product and strength, counsel on dosing schedules and missed dose rules, and advise on storage at 15–30°C.

They should explain common side effects, when to seek urgent care and encourage Yellow Card reporting for adverse reactions.

Pharmacists can offer repeat dispensing and adherence aids such as pill boxes and synchronised collection dates.

NHS Patient Support Advice

Where can patients find ongoing support while taking mesalazine?

Attend baseline and routine monitoring (renal function, LFTs), carry a summary of current medication and use local IBD nurse helplines for day‑to‑day management.

Ask your GP for fit notes or workplace adjustments during flares and discuss formulation changes with your gastroenterology team.

Quick FAQ

Can mesalazine affect fertility or pregnancy?

Discuss with your specialist; it is considered for use in pregnancy if indicated.

How long until I feel better?

Improvement often appears within 2–6 weeks, with full healing taking longer under specialist review.

What to do in an emergency?

Contact GP, A&E or NHS 111 for severe abdominal pain, persistent bleeding or chest pain.

Final Note On Access

Salofalk and other mesalazine products are prescription‑only and should be supplied via NHS prescription or a registered UK pharmacy.

In our online pharmacy, salofalk is available with a prescription, with discreet delivery to United Kingdom in 5–14 days.

Always keep prescriptions within the NHS system or with a registered pharmacy and consult your pharmacist or gastroenterology team before switching products.

Delivery Across United Kingdom